- Home
- BRN vs ATHA Comparison
BRN vs ATHA Comparison
Compare BRN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- ATHA
- Stock Information
- Founded
- BRN 1956
- ATHA 2011
- Country
- BRN United States
- ATHA United States
- Employees
- BRN N/A
- ATHA N/A
- Industry
- BRN Oil & Gas Production
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- BRN Energy
- ATHA Health Care
- Exchange
- BRN Nasdaq
- ATHA Nasdaq
- Market Cap
- BRN 17.6M
- ATHA 21.0M
- IPO Year
- BRN N/A
- ATHA 2020
- Fundamental
- Price
- BRN $1.62
- ATHA $0.28
- Analyst Decision
- BRN
- ATHA Buy
- Analyst Count
- BRN 0
- ATHA 4
- Target Price
- BRN N/A
- ATHA $11.25
- AVG Volume (30 Days)
- BRN 20.4K
- ATHA 209.7K
- Earning Date
- BRN 05-13-2025
- ATHA 05-14-2025
- Dividend Yield
- BRN N/A
- ATHA N/A
- EPS Growth
- BRN N/A
- ATHA N/A
- EPS
- BRN N/A
- ATHA N/A
- Revenue
- BRN $20,046,000.00
- ATHA N/A
- Revenue This Year
- BRN N/A
- ATHA N/A
- Revenue Next Year
- BRN N/A
- ATHA N/A
- P/E Ratio
- BRN N/A
- ATHA N/A
- Revenue Growth
- BRN N/A
- ATHA N/A
- 52 Week Low
- BRN $1.26
- ATHA $0.25
- 52 Week High
- BRN $3.20
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- BRN 48.22
- ATHA 31.57
- Support Level
- BRN $1.26
- ATHA $0.25
- Resistance Level
- BRN $1.79
- ATHA $0.33
- Average True Range (ATR)
- BRN 0.08
- ATHA 0.03
- MACD
- BRN -0.00
- ATHA -0.00
- Stochastic Oscillator
- BRN 33.33
- ATHA 26.67
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.